Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients
Open Access
- 1 April 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (4) , 580-582
- https://doi.org/10.1128/aac.33.4.580
Abstract
Sixty-three consecutive streptococcal blood isolates from neutropenic patients, represented mainly by viridans group streptococci, were evaluated in vitro for antibiotic susceptibility. Of these isolates, 79.3% were highly susceptible to penicillin (MIC, less than or equal to 0.12 microgram/ml). Overall, imipenem was the most active agent, followed by teicoplanin and vancomycin. All other agents showed decreased activity against streptococcal isolates that were not highly susceptible to penicillin.This publication has 10 references indexed in Scilit:
- Viridans streptococci septicemia in cancer patients: A clinical studyEuropean Journal of Epidemiology, 1987
- High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemiaJournal of Molecular Medicine, 1987
- Adult Respiratory Distress Syndrome in Patients with Severe NeutropeniaNew England Journal of Medicine, 1986
- Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus speciesJournal of Clinical Microbiology, 1984
- Neutropenia, fever, and infectionThe American Journal of Medicine, 1984
- STREPTOCOCCAL SEPSIS IN BONE MARROW TRANSPLANT PATIENTSThe Lancet, 1984
- SEPTICAEMIA CAUSED BY VIRIDANS STREPTOCOCCI IN NEUTROPENIC PATIENTS WITH LEUKAEMIAThe Lancet, 1983
- Speciation of the “Viridans” StreptococciAmerican Journal of Clinical Pathology, 1982
- Antimicrobial Susceptibilities of Species of Viridans StreptococciThe Journal of Infectious Diseases, 1979